INTERPACE BIOSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.00K.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $48.00K.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $59.00K, a 45.37% decline year-over-year.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $108.00K, a 10700.00% increase year-over-year.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2025 was $1.00K.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2022 was $108.00K, a 67.76% decline from fiscal 2021.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2021 was $335.00K.
- INTERPACE BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2015 was $2.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $1.00K 10-K · filed 2026-03-30 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-08-10 | |
| 2022-12-31 | $108.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $48.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $59.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $335.00K 10-K · filed 2023-03-27 | |
| 2021-03-31 | $108.00K 10-Q · filed 2021-05-11 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-11 | |
| 2019-06-30 | $73.00K 10-K · filed 2021-04-01 | $811.00K derived: sum of 4 quarters · filed 2021-04-01 |
| 2019-03-31 | $1.00K 10-K · filed 2021-04-01 | $1.02M derived: sum of 4 quarters · filed 2021-04-01 |
| 2018-12-31 | $594.00K 10-K/A · filed 2021-01-19 | $1.02M derived: sum of 4 quarters · filed 2021-01-19 |
| 2018-09-30 | $143.00K 10-K/A · filed 2021-01-19 | |
| 2018-06-30 | $285.00K 10-K/A · filed 2021-01-19 | |
| 2018-03-31 | $1.00K 10-K/A · filed 2021-01-19 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | |
| 2017-03-31 | $1.00K 10-Q · filed 2017-05-12 | |
| 2015-12-31 | $2.00K 10-K · filed 2016-03-30 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |